SCHEMBL286284

SCHEMBL286284

Cc1c(O)ccc(Br)c1CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALOX15 P16050 1/20 0.33
DRD4 P21917 1/20 0.33
TRPA1 O75762 1/20 0.33
ATM Q13315 1/20 0.33
ESR2 Q92731 7/20 0.32
ESR1 P03372 6/20 0.32
TYR P14679 1/20 0.32
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KLF10 Q13118 1/20 0.31
NQO2 P16083 1/20 0.31
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31098402 1.00 KDM4E (0.36) KDM4EALDH1A1HTR1DHTR1BGAA
SCHEMBL29683755 0.84 GABRA1 (0.33) DRD4GABRA1GABRG2GABRB3
SCHEMBL28291512 0.84 GABRA1 (0.33) DRD4GABRA1GABRG2GABRB3
SCHEMBL16369630 0.77 DRD4 (0.41) KDM4EALDH1A1ALOX15DRD4HPGD
SCHEMBL28815913 0.77 CYP1A2 (0.35)
SCHEMBL394136 0.76 TYR (0.40) KDM4EALDH1A1HTR1DHTR1BGAA
SCHEMBL31302207 0.76 TYR (0.40) KDM4EALDH1A1HTR1DHTR1BGAA
SCHEMBL286423 0.76 CYP3A4 (0.41) SMN1; SMN2ALOX15DRD4HPGDHSD17B10
SCHEMBL28417332 0.75 DRD4 (0.39) DRD4GABRA1GABRG2GABRB3
SCHEMBL29279709 0.74 MEP1B (0.37) ALOX15DRD4NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3083573-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC (US) 2024-08-07 EP disclosed
EP-3255993-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2021-01-27 EP disclosed
EP-3169672-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2020-04-29 EP disclosed
EP-3212619-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2019-11-20 EP disclosed
EP-3250204-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2019-10-30 EP disclosed
EP-3212618-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2019-07-10 EP disclosed
EP-2773199-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2019-04-10 EP disclosed
US-10208064-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. 2019-02-19 US disclosed
EP-3063142-B1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME (US) 2019-01-30 EP disclosed
US-10160751-B2 Inhibitors of the renal outer medullary potassium channel MERCK SHARP & DOHME CORP. 2018-12-25 US disclosed
US-20130217680-A1 Inhibitors of the Renal Outer Medullary Potassium Channel MERCK SHARP & DOHME LLC 2013-08-22 US disclosed
WO-2013090271-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-06-20 WO disclosed
WO-2013066714-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-05-10 WO disclosed
WO-2013066717-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-05-10 WO disclosed
WO-2013066718-A2 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-05-10 WO disclosed
WO-2013028474-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-02-28 WO disclosed
WO-2012058134-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO disclosed
EP-2427444-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2012-03-14 EP disclosed
WO-2010129379-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2010-11-11 WO disclosed
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME LLC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10160751-B2 Inhibitors of the renal outer medullary potassium channel KCNJ11, KCNJ1, SLC9A1 KDM4E 2424/4885ALDH1A1 1373/4885HTR1D 1065/4885
US-20130217680-A1 Inhibitors of the Renal Outer Medullary Potassium Channel KCNJ11, KCNJ1, KCNJ2 KDM4E 1908/4885ALDH1A1 1549/4885HTR1D 1040/4885
US-10208064-B2 Inhibitors of the renal outer medullary potassium channel KCNJ11, KCNJ1, KCNJ2 KDM4E 2184/4885ALDH1A1 1580/4885HTR1D 1003/4885
US-20100286123-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL KCNJ11, KCNJ1, KCNJ2 KDM4E 1977/4885ALDH1A1 1376/4885HTR1D 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.